AMZN CVS Daniel Jones Games RAD WBA

Rite Aid’s Tough Road Is Showing Some Positive Developments – Rite Aid Corporation (NYSE:RAD)

Rite Aid: On Its Own Again - Rite Aid Corporation (NYSE:RAD)

On Dec. 19, after the market closed, the administration workforce at Rite Aid (RAD) introduced monetary outcomes for the third quarter of the pharmacy chain’s 2019 fiscal yr. Regardless of having some respectable info for shareholders relating to subsequent yr, investor optimism was elusive, with market individuals placing the general market’s downturn forward of what any constructive issues administration needed to say. In all, what the info introduced by administration suggests is that, in some methods, the image for Rite Aid is getting higher, however with no apparent broader company technique in addition to persevering with to optimize what belongings are on the agency’s disposal, it’s onerous to consider there might be a lot upside from right here on out.

Some constructive developments

At the start, permit me to say the aim of this text is to not nitpick over quarterly outcomes for the retailer. That has been completed advert nauseam and what worth I can add there in comparison with what you have already got learn is nominal at greatest. For a take a look at the exact quarterly outcomes posted by Rite Aid in the course of the quarter, I recommend you take a look at the press launch on the subject. This text’s objective, as an alternative, is to concentrate on the current and the longer term, which is finally what is going to decide Rite Aid’s future success, or lack thereof.

That leads me right into a dialogue of what the foreseeable future seems to be like for the enterprise. For years, Rite Aid has suffered from falling margins, pushed partially by decrease comparable gross sales, the closure or sale of a few of its places, and business developments which have confirmed pricey for drugstore chains. Add to this elevated competitors coming on-line from corporations like Amazon (AMZN) and the truth that different gamers like CVS Well being (CVS) and Walgreens Boots Alliance (WBA) are far bigger and have larger economies of scale than Rite Aid, and it’s no marvel why shares of the enterprise are beneath $1 and implying a market cap on the enterprise of $840.6 million.

Even so, via its efforts to reinvent itself, there was some headway made by administration. As you’ll be able to see within the picture under, as an example, the corporate is optimistic that this present fiscal yr (ending March 2019) will probably be barely upbeat. Similar-retailer gross sales are forecasted to truly increase this yr by between zero.5% and 1%. It will comply with two consecutive years of similar-retailer gross sales declines by the enterprise. Complete income for the yr might be between $21.80 billion and $21.95 billion. That is noteworthy as a result of this would be the first full fiscal yr with out the 1,932 places Rite Aid bought to Walgreens (the deal closed March of 2018) in change for $four.157 billion. Administration additionally, by way of a authorized maneuver, managed to protect $2.2 billion value of NOLs (internet working losses) all through the gross sales course of.

*Taken from Rite Aid

Quick ahead to at present, although, and Rite Aid, regardless of having acquired a pleasant chunk of money, continues to be fairly closely indebted. Complete debt proper now’s $three.41 billion, whereas money and money equivalents stand at $410.04 million, implying internet debt immediately of about $three billion. Luckily, on Dec. 20, administration introduced that it had efficiently changed its revolving credit score facility with one other senior secured, asset-based mostly facility of $2.7 billion, plus it nailed down a $450 million senior secured time period mortgage facility. Each of those mature in 2023, but when administration can’t refinance or repay its present 6.125% senior notes in 2022, then these money owed will spring to mature in December of 2022. This construction implies a point of concern/wariness by lenders.

However struggles nonetheless exist

Because of administration’s onerous work, there’s no denying that Rite Aid is doing higher than it’d in any other case would, however this doesn’t imply the ache is over. As an example, should you take a look at administration’s steerage for the yr, the agency is predicted to generate EBITDA of between $545 million and $570 million. This appears stellar, however the enterprise will find yourself having to pay out an estimated $220 million in curiosity expense alone. Assuming none of its different changes are money based mostly (the $43 million in “other” very nicely is perhaps), this could translate to working money stream of between $325 million and $350 million, however then we have to issue out $250 million in deliberate gross capex to get free money move of between $75 million and $100 million.

Assuming this quite beneficiant state of affairs does come to fruition, it’s much better than a world the place Rite Aid generates unfavourable free money stream, however it leaves little in the best way for administration to concentrate on both progress or paying down debt. Finally, if Rite Aid’s administration group continues to push out efficiency like this, led by rising money movement brought on by rising comparable retailer gross sales, the corporate can and certain will survive, however will probably be a troublesome street, particularly as competitors on this area invariably grows.

This takes me again to an extra evaluation I had of Rite Aid. Again in February of this yr, I made the case that, basically, Rite Aid can be higher off merging with Albertsons within the deal the 2 companies introduced round that point. Regardless of virtually each reader disagreeing vehemently with my ideas, I maintained this. Between the time of that article’s publication and the time that Rite Aid and Albertsons ended their merger settlement in October, shares had plummeted 46.5% from $2.13 to $1.14. In my remaining article masking that matter, many readers maintained that I used to be mistaken, however I insisted that the agency was higher off merging and to today I adhere to that thought course of. Although it’s solely a comfort prize for me, shares of the pharmacy chain continued to free fall after the merger settlement was cancelled and, immediately, models are down a further 30.9% from the place they have been on the time of stated article’s publication whereas being down 54.7% from the time the merger was formally referred to as off.


Wanting again, I consider that it was a monumental error on buyers to not have adopted by way of with the merger with Albertsons, they usually have themselves in charge, at the least largely, for the decline that has taken place since then. Having stated that, simply because shares have dropped doesn’t imply that Rite Aid is a nasty prospect. If administration can proceed to develop similar-retailer gross sales and generate at the very least some constructive free money movement, then the agency might supply engaging prospects in the long term, however the street there, whether it is ever achieved, shall be an extended and hard one.

A group of oil and pure fuel buyers with a hankering for the E&P area: Crude Worth Insights is an unique group of buyers who’ve a style for oil and pure fuel companies. Our important curiosity is on money stream and the worth and progress prospects that generate the strongest potential for buyers. You get entry to a 50+ inventory mannequin account, in-depth money movement analyses of E&P companies, and a Reside Chat the place members can share their information and experiences with each other. Enroll now and your first two weeks are free!

Disclosure: I/we’ve no positions in any shares talked about, and no plans to provoke any positions inside the subsequent 72 hours. I wrote this text myself, and it expresses my very own opinions. I’m not receiving compensation for it (aside from from Looking for Alpha). I’ve no enterprise relationship with any firm whose inventory is talked about on this article.

window.SA = “App”:”name”:”SA”,”fullName”:”Seeking Alpha”,”type”:”regular”,”host”:””,”emailHost”:””,”pro”:false,”proPlus”:false,”contributorCenter”:false,”realHostName”:””,”isCms”:false,”cancelPV”:false,”isSharkPreview”:false,”usersOnSite”:”7,186,003″,”assetHosts”:[“”,””,””,””],”moneData”:”params”:”subscribe_color=control”,”assetHost”:””,”userEchoHost”:””,”env”:”dev”:false,”staging”:false,”production”:true,”test”:false,”gaAccountId”:”UA-1466493-1″,”comscoreAccountId”:8500672,”fbAppId”:”624608951014846″,”twitterAccountName”:”SeekingAlpha”,”rollbarToken”:”5edf110be2fc4cecb32637fc421111e2″,”perimeterXAppId”:”PXxgCxM9By”,”embedlyKey”:”a6da93fdfc49472099ce63260954716b”,”mp”:false,”chat”:”host”:””,”pageConfig”:”Refresher”:”active”:false,”Data”:”article”:”id”:4229786,”title”:”Rite Aid’s Tough Road Is Showing Some Positive Developments”,”stub”:false,”primaryTicker”:”rad”,”primaryIsCrypto”:false,”isTranscript”:false,”isSlides”:false,”twitContent”:”$RAD – Rite Aid’s Tough Road Is Showing Some Positive Developments”,”isProArticle”:false,”isProPaywall”:false,”paywallReason”:null,”isArchived”:false,”inEmbargo”:false,”is_wsb”:false,”isAuthorNewsletter”:false,”titleTest”:null,”archiveOn”,”isProNoEmbargo”:false,”url”:””,”isFreeMpArticle”:true,”isFreeProArticle”:null,”isInsight”:false,”insightSlug”:””,”price_at_publication”:”0.79″,”themes”:[“earnings”,”sa-exclusive”,”us”,”drug-stores”,”services”,”article”],”from_liftigniter”:false,”isAnyProArticle”:false,”allowMpPromotion”:true,”article_datetime”:”2018-12-22T12:05:10.000-05:00″,”isEtf”:false,”taggedUrlsHtml”:”u003cspan itemscope itemtype=’’u003eu003ca href=’’ sasource=’article_navigation’ itemprop=’url’u003eu003cspan itemprop=’title’u003eServicesu003c/spanu003eu003c/au003eu003c/spanu003e, u003cspanu003eDrug Storesu003c/spanu003e, u003cspanu003eEarningsu003c/spanu003e”,”isFidelityEducationPage”:false,”contentData”:null,”marketingBullet”:”Looking for a community to discuss ideas with? Crude Value Insights features a chat room of like-minded investors sharing investing ideas and strategies. u003ca href=’/checkout?service_id=mp_1209′ sasource=’mp_marketing_text_top’u003eGet started today »u003c/au003e”,”author”:”id”:69675,”userId”:9866571,”slug”:”daniel-jones”,”exclusiveResearch”:”title”:”Crude Value Insights”,”short_pitch”:”Robust cash flow analyses of oil and gas companies”,”id”:1209,”tagId”:163495,”name”:”Daniel Jones”,”picture_url”:””,”is_brand_author”:false,”show_managed_account”:false,”comments”:”discussion_status”:zero,”discussion_message”:”Comments disabled for this article”,”brand”:null,”firstResearchAuthor”:”id”:69675,”slug”:”daniel-jones”,”pageType”:”article”,”articleModeratedMsg”:null,”qmChartData”:”isMF”:false,”isETF”:false,”isCEF”:false,”etfData”:,”isCrypto”:false,”chartTimes”:”MARKET_OPEN_TS”:1545489000,”END_TIME”:”12/21/2018 16:00″,”1D”:”12/21/2018 9:30″,”PREV_1D”:”12/21/2018 9:30″,”5D”:”12/17/2018 9:30″,”1M”:”11/21/2018 9:30″,”6M”:”06/22/2018 16:00″,”1Y”:”12/22/2017 16:00″,”5Y”:”12/20/2013 16:00″,”10Y”:”12/22/2008 16:00″,”20Y”:”12/22/1998 16:00″,”MAX”:”01/01/1950 9:30″,”object”:”id”:1435,”name”:”RAD”,”slug”:”rad”,”visible”:true,”searchable”:true,”tag_kind_id”:52,”is_defunct”:false,”updated_on”:”2018-10-21T03:23:35.000-04:00″,”content”:”Rite Aid Corporation”,”Ads”:”slots”:[“container”:”article-left-slot-2″,”data”:”name”:”/6001/”,”disable_collapse_empty_div”:false,”targeting”:”tile”:160,”size”:[[160,600],”fluid”],”str”:”160×600,fluid”,”container”:”article-left-slot-3″,”data”:”name”:”/6001/”,”disable_collapse_empty_div”:false,”targeting”:”tile”:162,”size”:[[160,600],”fluid”],”str”:”160×600,fluid”,”delay”:true,”whenOutOfView”:”article-left-slot-2″,”container”:”article-right-slot-1″,”data”:”name”:”/6001/”,”disable_collapse_empty_div”:false,”targeting”:”tile”:1,”size”:[[300,250],[300,600],”fluid”],”str”:”300×250,300×600,fluid”,”cls”:”mb25″,”flex”:true,”container”:”article-right-slot-2″,”data”:”name”:”/6001/”,”disable_collapse_empty_div”:false,”targeting”:”tile”:100,”size”:[[300,100]],”str”:”300×100″,”cls”:”mb25″,”container”:”article-right-slot-3″,”data”:”name”:”/6001/”,”disable_collapse_empty_div”:false,”targeting”:”tile”:2,”size”:[[300,252],”fluid”],”str”:”300×252,fluid”,”cls”:”mb25″,”native”:true,”container”:”article-middle-slot-1″,”data”:”name”:”/6001/”,”disable_collapse_empty_div”:false,”targeting”:,”size”:[[640,40]],”str”:”640×40″,”container”:”instream_recommendation_ad”,”data”:”name”:”/6001/”,”disable_collapse_empty_div”:false,”targeting”:”tile”:50,”size”:[[3,3],”fluid”],”str”:”3×3,fluid”,”delay”:true,”delta”:500],”testScroll”:true,”disabled”:false,”kvs”:”d”:[“news”,”sectors”],”t”:[“news”,”earnings”,”sa-exclusive”,”us”,”drug-stores”,”services”,”article”],”aid”:”4229786″,”a”:”daniel-jones”,”cnt”:[“etrfin”,”fed”,”taxes”,”ssga6″,”fnk2″,”port”],”ldr”:[“conglomerates”,”commodities”],”prstock”:”true”,”mp_free_article”:”true”,”tickerbundle”:[“growth”,”value”,”mid-cap”,”consumer-services”],”pr”:”rad”,”s”:[“amzn”,”cvs”,”wba”,”rad”],”ab_subscribe_color”:”control”,”Paths”:”int”:”adsAPI”:”src”:””,”id”:”sa-ads-api”,”ext”:[“src”:””,”id”:”ie”,”src”:””,”id”:”gpt”,”src”:””,”id”:”sb”,”src”:””,”id”:”ga”,”src”:””,”id”:”facebook-jssdk”],”lastRequested”:”2018-12-22 18:25:12 -0500″,”SlugsPrices”:”disabled”:false,”proOpenHouse”:”active”:false,”end_date”:”2017-03-20T06:00:00.000-04:00″,”proFlashSale”:”active”:false,”end_date”:”2017-03-23T00:00:00.000-04:00″,”saSource”:null,”name”:”article”,”useSQuoteBackup”:null,”headerConfig”:”noNotificationsMenu”:null,”nonFixed”:null,”tabless”:null,”activeTab”:”stock-ideas”,”modules”:,”requires”:[],”trackq”:[],”exceptions”:[],”gptInit”:false;